Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Dent

Showing results (81-90 of 395) with videos related to

Pageof 40
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 28, 2009
Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapyPaul Dent, David T Curiel, Paul B Fisher, et al.
Leukemia Research|November 15, 2011
LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanismRoberto Rosato, Stefanie Hock, Paul Dent, et al.
Anti-Cancer Drugs|February 27, 2023
A novel combination of isovanillin, curcumin, and harmine (GZ17-6.02) enhances cell death and alters signaling in actinic keratoses cells when compared to individual components and two-component combinationsZachary A Bordeaux, Shawn G Kwatra, Laurence Booth, et al.
Cancer Biology & Therapy|February 16, 2008
Acquired and innate resistance to the cancer-specific apoptosis-inducing cytokine, mda-7/IL-24: not insurmountable therapeutic problemsDevanand Sarkar, Paul Dent, David T Curiel, et al.
Molecular Pharmacology|July 6, 2004
Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridolNing Gao, Yun Dai, Mohamed Rahmani, et al.
Blood|September 6, 2005
Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stressNing Gao, Mohamed Rahmani, Xianglin Shi, et al.
Advances in Cancer Research|February 7, 2018
Unconventional Approaches to Modulating the Immunogenicity of Tumor CellsLaurence Booth, Jane L Roberts, John Kirkwood, et al.
Cancer Biology & Therapy|June 21, 2018
Valproate augments Niraparib killing of tumor cellsLaurence Booth, Jane L Roberts, Rumeesa Rais, et al.
The Journal of Biological Chemistry|August 20, 2005
Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translationMohamed Rahmani, Eric Maynard Davis, Cheryl Bauer, et al.
Applied Spectroscopy|August 10, 2019
Coupled Turbidity and Spectroscopy Problems: A Simple Algorithm for Volumetric Analysis of Optically Thin or Dilute, In Vitro Bacterial Cultures in Various MediaSteven Ortiz, Richard T McDonough, Paul Dent, et al.
Pageof 40

Showing results (81-90 of 395) with videos related to

Sort By:
Pageof 40
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 28, 2009
Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapyPaul Dent, David T Curiel, Paul B Fisher, et al.
Leukemia Research|November 15, 2011
LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanismRoberto Rosato, Stefanie Hock, Paul Dent, et al.
Anti-Cancer Drugs|February 27, 2023
A novel combination of isovanillin, curcumin, and harmine (GZ17-6.02) enhances cell death and alters signaling in actinic keratoses cells when compared to individual components and two-component combinationsZachary A Bordeaux, Shawn G Kwatra, Laurence Booth, et al.
Cancer Biology & Therapy|February 16, 2008
Acquired and innate resistance to the cancer-specific apoptosis-inducing cytokine, mda-7/IL-24: not insurmountable therapeutic problemsDevanand Sarkar, Paul Dent, David T Curiel, et al.
Molecular Pharmacology|July 6, 2004
Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridolNing Gao, Yun Dai, Mohamed Rahmani, et al.
Blood|September 6, 2005
Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stressNing Gao, Mohamed Rahmani, Xianglin Shi, et al.
Advances in Cancer Research|February 7, 2018
Unconventional Approaches to Modulating the Immunogenicity of Tumor CellsLaurence Booth, Jane L Roberts, John Kirkwood, et al.
Cancer Biology & Therapy|June 21, 2018
Valproate augments Niraparib killing of tumor cellsLaurence Booth, Jane L Roberts, Rumeesa Rais, et al.
The Journal of Biological Chemistry|August 20, 2005
Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translationMohamed Rahmani, Eric Maynard Davis, Cheryl Bauer, et al.
Applied Spectroscopy|August 10, 2019
Coupled Turbidity and Spectroscopy Problems: A Simple Algorithm for Volumetric Analysis of Optically Thin or Dilute, In Vitro Bacterial Cultures in Various MediaSteven Ortiz, Richard T McDonough, Paul Dent, et al.
Pageof 40